Skip to main content
. 2017 Jan 18;13(3):1949–1957. doi: 10.3892/ol.2017.5616

Figure 1.

Figure 1.

Association between total serum testosterone levels in patients with prostate cancer and (A) tumor aggressiveness, (B) total Gleason score, (C) clinical stage of tumor and (D) PSA levels at diagnosis. Results are presented as the mean ± standard error. PSA, prostate-specific antigen.